Cargando…

Robust controller for artificial pancreas for patients with type-1 diabetes

PURPOSE: The target of this paper is to design a simple and an efficient controller for artificial pancreas (AP) system for blood glucose (BG) regulation in type-1 diabetic mellitus (T1DM) patient. Bergman’s intravenous model is chosen for the controller design as the model is minimum ordered model...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandal, Sharmistha, Sutradhar, Ashoke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226027/
http://dx.doi.org/10.1007/s42600-023-00285-9
_version_ 1785050500763222016
author Mandal, Sharmistha
Sutradhar, Ashoke
author_facet Mandal, Sharmistha
Sutradhar, Ashoke
author_sort Mandal, Sharmistha
collection PubMed
description PURPOSE: The target of this paper is to design a simple and an efficient controller for artificial pancreas (AP) system for blood glucose (BG) regulation in type-1 diabetic mellitus (T1DM) patient. Bergman’s intravenous model is chosen for the controller design as the model is minimum ordered model of T1DM patient. METHOD: A multi-objective output feedback controller has been designed for AP system considering robustness, disturbance rejection, and transient criterion. Considering H(∞), pole-placement, and H(2) constraints, a control algorithm has been developed and has been solved using linear matrix inequality (LMI) technique. RESULT: As a testing platform of the intravenous model-based designed controller, UVa/Padova T1DM metabolic simulator has been chosen which uses subcutaneous insulin delivery method. The controller has been tested in the presence of unannounced meal disturbances. Experimental results show that the controller regulates BG level very efficiently with lesser amount of insulin and avoids hypoglycemia effect. In the presence of external noises like glucose sensor noise and insulin pump error, the robustness of the controller has been checked. The performance of the controller has been compared with compound internal model control (IMC) strategy reported earlier for same meal scenario. CONCLUSION: The designed multi-objective controller gives better performance metrices than compound IMC controller.
format Online
Article
Text
id pubmed-10226027
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-102260272023-05-30 Robust controller for artificial pancreas for patients with type-1 diabetes Mandal, Sharmistha Sutradhar, Ashoke Res. Biomed. Eng. Original Article PURPOSE: The target of this paper is to design a simple and an efficient controller for artificial pancreas (AP) system for blood glucose (BG) regulation in type-1 diabetic mellitus (T1DM) patient. Bergman’s intravenous model is chosen for the controller design as the model is minimum ordered model of T1DM patient. METHOD: A multi-objective output feedback controller has been designed for AP system considering robustness, disturbance rejection, and transient criterion. Considering H(∞), pole-placement, and H(2) constraints, a control algorithm has been developed and has been solved using linear matrix inequality (LMI) technique. RESULT: As a testing platform of the intravenous model-based designed controller, UVa/Padova T1DM metabolic simulator has been chosen which uses subcutaneous insulin delivery method. The controller has been tested in the presence of unannounced meal disturbances. Experimental results show that the controller regulates BG level very efficiently with lesser amount of insulin and avoids hypoglycemia effect. In the presence of external noises like glucose sensor noise and insulin pump error, the robustness of the controller has been checked. The performance of the controller has been compared with compound internal model control (IMC) strategy reported earlier for same meal scenario. CONCLUSION: The designed multi-objective controller gives better performance metrices than compound IMC controller. Springer International Publishing 2023-05-29 2023 /pmc/articles/PMC10226027/ http://dx.doi.org/10.1007/s42600-023-00285-9 Text en © The Author(s), under exclusive licence to The Brazilian Society of Biomedical Engineering 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Mandal, Sharmistha
Sutradhar, Ashoke
Robust controller for artificial pancreas for patients with type-1 diabetes
title Robust controller for artificial pancreas for patients with type-1 diabetes
title_full Robust controller for artificial pancreas for patients with type-1 diabetes
title_fullStr Robust controller for artificial pancreas for patients with type-1 diabetes
title_full_unstemmed Robust controller for artificial pancreas for patients with type-1 diabetes
title_short Robust controller for artificial pancreas for patients with type-1 diabetes
title_sort robust controller for artificial pancreas for patients with type-1 diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226027/
http://dx.doi.org/10.1007/s42600-023-00285-9
work_keys_str_mv AT mandalsharmistha robustcontrollerforartificialpancreasforpatientswithtype1diabetes
AT sutradharashoke robustcontrollerforartificialpancreasforpatientswithtype1diabetes